Background: Candida species are the third most common cause of pediatric health care–associated bloodstream infection in the United States and Europe. To our knowledge, this report from the ...

Background: Invasive candidiasis is an increasing problem in neonatal intensive care units worldwide and is an important cause of morbidity, mortality and prolongation of hospital stay. Despite ...

Invasive candidiasis represents a spectrum of life-threatening fungal infections that commonly afflict critically ill patients. It encompasses candidemia—bloodstream invasion by Candida species—and ...

Please provide your email address to receive an email when new articles are posted on . The FDA Antimicrobial Drugs Advisory Committee voted on Wednesday 14-1 in favor of the use of rezafungin for the ...

Invasive candidiasis, which in many patients represents a life-threatening condition, is “largely a disease of medical progress,” according to the Guidelines. Risk factors include the use of ...

SAN DIEGO & CAMBRIDGE, England--(BUSINESS WIRE)--Cidara Therapeutics, Inc. (NASDAQ: CDTX) and Mundipharma today announced positive topline data from the pivotal ReSTORE Phase 3 clinical trial ...

SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing therapies designed to save lives and improve the standard of care for patients ...

Credit: Melinta Therapeutics. Rezzayo is supplied as a solid (cake or powder) in a single-dose vial containing 200mg of rezafungin. Rezzayo ™ (rezafungin for injection) is now available for the ...

Please provide your email address to receive an email when new articles are posted on . Weekly injectable is first new treatment for candidemia and invasive candidiasis in more than a decade. Rezzayo ...

Michail Lionakis, MD, ScD, chief of the fungal pathogenesis section at the National Institutes of Health, is the senior author of this study. Invasive candidiasis is a life-threatening fungal ...

A yeast infection is pesky, yet very common. It's estimated that about three out of four women will experience at least one vaginal yeast infection in their lifetime. Yeast infections are caused by ...